(Q34514151)

2 August 2017

Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age. (English)

1 reference

2 August 2017

1 reference

Jack F Price

1

1 reference

2 August 2017

Naomi J Kertesz

2

1 reference

2 August 2017

Christopher S Snyder

3

1 reference

2 August 2017

Richard A Friedman

4

1 reference

2 August 2017

Arnold L Fenrich

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Journal of the American College of Cardiology

2 August 2017

1 reference

2 August 2017

39

1 reference

2 August 2017

3

1 reference

2 August 2017

517-520

1 reference

Supraventricular tachycardia in children: Clinical features, response to treatment, and long-term follow-up in 217 patients

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Flecainide acetate for resistant arrhythmias in the young: efficacy and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Paediatric use of flecainide in supraventricular tachycardia: clinical efficacy and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. The Pediatric Electrophysiology Society

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Efficacy and safety of radiofrequency ablation in infants and young children < 18 months of age

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Efficacy and safety of oral sotalol in early infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Sotalol for refractory arrhythmias in pediatric and young adult patients: initial efficacy and long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Flecainide acetate for treatment of tachyarrhythmias in children: review of world literature on efficacy, safety, and dosing

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Flecainide and amiodarone: combined therapy for refractory tachyarrhythmias in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Combined sotalol and flecainide given at low dosage in patients with the Wolff-Parkinson-White syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Radiofrequency catheter ablation of incessant, medically resistant supraventricular tachycardia in infants and small children

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Late enlargement of radiofrequency lesions in infant lambs. Implications for ablation procedures in small children

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Radiofrequency catheter ablation for supraventricular tachycardia. Should it be used in infants and small children?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Supraventricular tachycardia due to Wolff-Parkinson-White syndrome in children: early disappearance and late recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Wolff-Parkinson-White syndrome and supraventricular tachycardia during infancy: management and follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Ectopic automatic atrial tachycardia in children: clinical characteristics, management and follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Electrophysiologic and pharmacologic characteristics of automatic ectopic atrial tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Factors that predict spontaneous remission of ectopic atrial tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Treatment of atrial ectopic tachycardia in infants < 6 months old.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Permanent junctional re-entry tachycardia. A multicentre long-term follow-up study in infants, children and young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Clinical course of persistent junctional reciprocating tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Clinical safety profile of sotalol in patients with arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

Pharmacokinetics and pharmacodynamics of sotalol in a pediatric population with supraventricular and ventricular tachyarrhythmia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901773-9

7 January 2021

10.1016/S0735-1097(01)01773-9

Identifiers

DOI

1 reference

2 August 2017

1 reference